Latest news with #EUR5
New Straits Times
15-05-2025
- Automotive
- New Straits Times
FIA cuts controversial F1 driver swearing fines
PARIS: Formula One's governing body on Wednesday reduced the controversial penalties dished out to drivers for swearing after a backlash from the grid. Ahead of this weekend's Emilia Romagna Grand Prix, the FIA has removed the risk of a race ban and cut the "base maximum penalty from EUR10,000 ($11,180) to EUR5,000." Importantly the new guidelines given to race stewards now differentiates between swearing in "controlled" or "uncontrolled" circumstances. This will give drivers more latitude for turning the air blue in the heat of the moment, for example on the team radio during races. "Controlled environments include settings such as press conferences, while uncontrolled environments refer to spontaneous comments made by drivers or teams when on track or during a rally stage," a statement from the FIA explained. It went on to describe the development as "major improvements" to appendix B of the sporting code. The previous policy had come in for intense criticism from the likes of four-time world champion Max Verstappen, who was sanctioned for swearing at a press conference in Singapore. The drivers will have a chance to give their reaction to the toned-down swearing policy at Imola on Thursday at the traditional pre-race round of press conferences. The relaxation in the rules came after an open letter to FIA president Mohammed Ben Sulayem, up for re-election later this year, from the drivers who asked the FIA to treat them "like adults." In February, Williams driver Carlos Sainz questioned the FIA's hardline approach to the subject. Sainz said while it was reasonable to expect drivers to avoid swearing while speaking in a public setting such as a news conference, it was a different matter while they were on the track. "What we say on the (car) radio, I don't agree with what is happening," said the Spaniard. "I think you can not be too tough on these kinds of things because you cannot understand the pressure and adrenaline and the way we feel in the car when we open the radio. "And I feel for F1 it is good to have those moments because you see the real driver."
Associated Press
14-04-2025
- Business
- Associated Press
DHL Supply Chain strengthens Life Sciences & Healthcare infrastructure with new Pharma Hub in Singapore
SINGAPORE - Media OutReach Newswire - 14 April 2025 - DHL Supply Chain, the global leader in contract logistics, launched a new Pharma Hub in Singapore, a dedicated facility for pharmaceutical logistics. The €10 million facility is part of DHL Group's €500 million investment into Asia Pacific to bolster its Life Sciences and Healthcare (LSHC) infrastructure across all business units. DHL Supply Chain's new Pharma Hub in Singapore This strategic initiative reflects DHL Group's global focus on the healthcare sector as part of its Strategy 2030, which introduced the new 'DHL Health Logistics' sector brand to drive cross-divisional growth. The LSHC sector currently contributes EUR5 billion to DHL's global revenue, underscoring its significance in the Group's growth strategy. From left to right: Javier Bilbao (CEO, DHL Supply Chain APAC), Tobias Meyer (CEO, DHL Group), Eunis Hew (Managing Director, DHL Supply Chain Singapore), and Edwin Wong (CEO, DHL Supply Chain Southeast Asia) 'At DHL Supply Chain, we are committed to supporting the rapidly growing LSHC sector in Asia Pacific where there is a growing demand for transformative healthcare solutions due to longer lifespans, personalized treatments and rising consumer expectations. By 2030, the region's medical market is projected to reach USD138 billion (~€127 billion), reflecting the critical need for resilient and efficient supply chains. As part of DHL Group's Strategy 2030, we have invested ahead to strengthen our infrastructure and capabilities, ensuring we can meet the evolving and increasingly complex needs of our customers. Our investment goes beyond building warehouses or expanding networks. It is about building a foundation across all our business units that enables faster, more reliable delivery of life-saving medicines and healthcare products. In a region where healthcare demand is surging, we enable our customers to focus on innovation and patient care. At the same time, we handle the complexities of supply chain management across all logistics touchpoints - from storage, order fulfillment, and distribution to global shipping and last-mile delivery. This is how we deliver real value: by turning challenges into opportunities and ensuring that every link in the healthcare supply chain works seamlessly,' explained Javier Bilbao, CEO, DHL Supply Chain Asia Pacific. The new 8,200 square meters Pharma Hub at 8 Jurong Pier in Singapore features specialized temperature-controlled zones including ambient (15°C to 25°C) and cold room (2°C to 8°C), ensuring precise storage conditions for sensitive healthcare products. It is Good Manufacturing Practice (GMP) compliant with advanced cold chain infrastructure, including airtight loading docks and dedicated anterooms, ensures uninterrupted temperature stability throughout the logistics process. Future plans are in place to enable pharma related value-added services including redressing activities. Strategically located near Tuas Bio-Medical Park, the Pharma Hub offers seamless connectivity to Changi Airport and Tuas Mega Port, enabling efficient regional and global distribution for pharmaceutical partners. 'Singapore is laser-focused on becoming a global leader in life sciences and medtech innovation. The country's ambitions are backed by investments, such as a top-up of SGD$3 billion (~€2 billion) in Budget 2025 to attract investments in sectors like semiconductors and life sciences, as well as other key initiatives, including the National Research, Innovation and Enterprise (RIE). With the new Pharma Hub in Jurong, we have over 36,000 square meters of warehouse space in Singapore dedicated to LSHC operations. Our current operations include being the regional distribution centers for multiple medical device multi-nationals, clinical trials support and other value-added services,' said Eunis Hew, Managing Director, DHL Supply Chain Singapore. A successful LSHC supply chain requires several critical factors – robust warehouse infrastructure, skilled personnel and innovative solutions. Together, these elements enable DHL Supply Chain to meet the unique demands of the healthcare industry and deliver exceptional value to customers. Supporting growth with robust infrastructure Even before the recent announcement of DHL Group's €2 billion investment into the sector, DHL Supply Chain has already made strategic early investments in the region. These key projects, supporting the growing LSHC industry and helping customers navigate evolving demands, include: DHL Supply Chain's extensive network of Good Distribution Practice (GDP)/ GMP-compliant facilities, featuring specialized temperature zones, humidity control, and uninterrupted cold chain capabilities, ensures the integrity of sensitive products such as pharmaceuticals and medical devices. Its specialized logistics solutions, including multi-temperature storage, transport, and complex and customized white glove express delivery for extremely time- and temperature-sensitive deliveries, position it to address structural shifts in the LSHC market. Globally, DHL Group has announced an investment of €2 billion by 2030 to boost integrated healthcare solutions. It also recently acquired CRYOPDP, a specialty courier providing end-to-end temperature-controlled solutions and white-glove services designed for the LSHC industry. Skilled personnel with the right expertise to navigate complexities Many pharmaceutical products require strict temperature control during storage and transportation, as well as adherence to stringent LSHC industry regulations. Skilled personnel are crucial in managing cold chain logistics, ensuring products remain within specified temperature ranges to maintain efficacy and safety. These professionals also navigate complex regulations and ensure compliance with local and international laws governing the storage, handling, and transportation of medical products. With over 2,600 healthcare logistics experts and more than 40 full-time pharmacists in Asia Pacific, DHL Supply Chain manages the complexities of healthcare logistics for its customers. From regulatory compliance to proper product handling, DHL Supply Chain's trained team ensures that every step of the supply chain operates seamlessly and efficiently. Innovative solutions to drive efficiency and resilience Innovation is at the heart of DHL Supply Chain's LSHC operations. DHL drives efficiency and enables proactive decision-making by integrating automation, robotics, and AI-powered tracking systems into its operations. For example: By continuously investing in innovative solutions, DHL Supply Chain ensures its operations are equipped to meet the evolving needs of the healthcare sector, from research and development to patient delivery. 'Modern healthcare depends on more than just a physician's expertise. It requires scale, connectivity, and constant collaboration between manufacturers, researchers and medical experts worldwide. Healthcare can only work if its logistics do too,' Bilbao added. With the investments in new additions and expanded capabilities, DHL Supply Chain will operate over 80 facilities with over 700,000 square meters of fully compliant warehousing space in 13 countries across Asia Pacific. Hashtag: #DHL The issuer is solely responsible for the content of this announcement. DHL – The logistics company for the world
Yahoo
05-03-2025
- Business
- Yahoo
Bilfinger SE (BFLBF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Improved ...
Revenue: Increased by 12% to more than EUR5 billion for 2024. EBITDA Margin: Improved from 4.3% to 5.2%, a 39% increase. Free Cash Flow: Increased by 55% to EUR189 million. Earnings Per Share: EUR4.79 for the full year 2024. Dividend Proposal: EUR2.40 per share for 2024. Orders Received: Up by 13% to EUR5.3 billion. Order Backlog: Reported a 22% improvement. Net Profit: Adjusted net profit increased to EUR169 million. Cash Conversion Rate: 71%, with an adjusted rate of 88%. Net Debt/EBITDA: 0.54%, well below the 2.00 upper ceiling. Warning! GuruFocus has detected 4 Warning Signs with BBY. Release Date: March 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Bilfinger SE (BFLBF) achieved all financial targets for 2024, with orders received up by 13% and revenue up by 12%. EBITDA margin improved from 4.3% to 5.2%, indicating a solid financial performance. The company reported a significant increase in free cash flow, from EUR122 million to EUR189 million, marking a 55% improvement. Bilfinger SE (BFLBF) maintained a positive cash flow for six consecutive quarters, showcasing effective working capital management. The company proposed a dividend of EUR2.40 for 2024, reflecting a payout ratio of 53% in line with its dividend policy. The LTIF (Lost Time Injury Frequency) indicator showed a negative trend, highlighting a deterioration in occupational safety. EBITDA margin in the international segment decreased from 5.4% to 1.6% in Q4 due to risk provisioning for discontinued projects in North America. Orders received in the international segment dropped by 22%, partly due to slowed decision-making in the US following a new administration. The company faces challenges in the chemical and petrochemical industries, particularly in Germany, due to regional differences and market conditions. The guidance for 2025 includes a broad range for revenue and EBITDA, reflecting uncertainties in economic scenarios and political decisions. Q: Can you provide more details on the broad range of guidance for 2025, especially concerning the segment Europe? A: Thomas Schulz, CEO: The range is influenced by various factors, including political decisions and economic scenarios. In the US, delays in government approvals could impact the lower end of our guidance. The Middle East is performing as expected, with opportunities for growth. In Europe, the outcome of the German election and subsequent infrastructure investments will significantly affect our performance. If these investments materialize, we could see growth towards the higher end of our guidance. Q: Is the high cash conversion rate of around 90% sustainable going forward? A: Matti Jaekel, CFO: While achieving a 90% cash conversion rate is favorable, we are targeting an 80% rate as a sustainable midterm goal. The recent high rates were supported by favorable order intake and advance payments, which may not be consistent every year. We aim to maintain an 80% rate as a realistic target. Q: Regarding the US market, are there any remaining financial risks with the last construction projects? A: Thomas Schulz, CEO: We are finalizing the last remaining construction project, and it is properly provisioned. There are no new developments regarding the Sapelo Island incident in Georgia. Q: Why is there only a moderate margin increase expected for this year compared to last year? A: Thomas Schulz, CEO: This year is unique due to the US election and the German government's slow activity, impacting market dynamics. We aim for sustainable, profitable growth and expect margin expansion as political and economic conditions stabilize, particularly in the second half of 2025. Q: How is the order intake progressing in Europe and the US, considering the current economic conditions? A: Thomas Schulz, CEO: In the US, despite a temporary slowdown due to government activities, demand remains strong, particularly in energy-related industries. In Europe, while the chemical industry faces challenges, we continue to receive orders. Political decisions on infrastructure and energy costs will influence future order volumes. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
21-02-2025
- Business
- Yahoo
Repsol SA (REPYF) Q4 2024 Earnings Call Highlights: Strong Cash Flow and Dividend Growth Amidst ...
Adjusted Income: EUR3.3 billion for 2024. Operating Cash Flow: EUR6.3 billion, ahead of guidance. Total Shareholder Remuneration: EUR1.9 billion, 31% of operating cash flow. Cash Dividend: Increased by 30% to EUR0.90 per share. Net Debt: EUR5 billion, reduced by EUR0.5 billion from September. Total Liquidity: EUR9.5 billion, over 3.5 times short-term debt. Net CapEx: EUR5.7 billion, excluding EUR0.3 billion from Colombia disposal. Upstream Division Adjusted Income: EUR1.5 billion, 16% lower year over year. Full Year Production: 571,000 barrels per day. Industrial Division Earnings: EUR1.5 billion, EUR1.3 billion lower year over year. Customer Division Adjusted Income: EUR659 million, 7% increase over 2023. Customer Division EBITDA: EUR1.2 billion, 13% improvement year over year. Low Carbon Generation Adjusted Income: EUR23 million negative. Renewable Capacity: 3.7 gigawatts by year-end 2024. Projected 2025 Production: 530,000 to 550,000 barrels per day. 2025 Cash Flow from Operations: EUR6 billion to EUR6.5 billion. 2025 Net CapEx: EUR3.5 billion to EUR4 billion. 2025 Cash Dividend: EUR0.975 per share, 8.3% increase over 2024. Warning! GuruFocus has detected 4 Warning Signs with BILI. High Yield Dividend Stocks in Gurus' Portfolio This Powerful Chart Made Peter Lynch 29% A Year For 13 Years How to calculate the intrinsic value of a stock? Release Date: February 20, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Repsol SA (REPYF) achieved an adjusted income of EUR3.3 billion and delivered EUR6.3 billion of operating cash flow, surpassing their guidance. The company increased its cash dividend by approximately 30% to EUR0.90 per share and redeemed 60 million shares, equivalent to 5% of its share capital. Net debt was reduced to EUR5 billion, with a gearing ratio of 2.4% excluding leases, indicating strong financial management. Repsol SA (REPYF) plans to invest in key growth projects, including Leon Castile in the Gulf and Pikka in Alaska, which are expected to contribute significantly to future production. The company is committed to a net CapEx of EUR16 billion to EUR19 billion over four years, with a focus on low-carbon projects and upstream development. Full-year adjusted income in the upstream division was EUR1.5 billion, 16% lower year over year, due to lower gas prices and volumes. Production was impacted by divestments and force majeure events in Libya, with full-year production at the lower end of guidance. The industrial division's earnings were EUR1.5 billion, EUR1.3 billion lower year over year, mainly due to normalization of refining margins. The chemicals business continued to face challenges, with a negative EBITDA contribution despite a slight improvement in margins. Repsol SA (REPYF) faces potential challenges in the US renewables market due to financial conditions and inflationary pressures. Q: Can you provide more details on the production guidance for 2025 and the factors influencing it? A: Josu Jon Imaz San Miguel, CEO, explained that Repsol aims to be at the higher end of the 530,000 to 550,000 barrels per day range. Factors include increased production in Libya and new wells, offset by divestments in Colombia and Trinidad and Tobago. The Leon Castile and Pikka projects will contribute to production, but Pikka's impact will be more significant in 2026. Q: What are the plans for asset disposals in 2025, and what is the expected timing? A: Repsol plans to achieve EUR2 billion in disposals, with EUR300 million from Colombia and EUR1.5 billion from the low-carbon business, including asset rotations. The first half of the year will see significant progress, with transactions in Spain and the US expected to close soon. Q: Is Repsol still considering an IPO for its upstream business, or are there other options? A: The company is preparing for a liquidity event by the end of Q1 2026, with options including an IPO, reverse takeover, or private liquidity event. The focus is on optimizing the upstream portfolio and increasing cash flow from operations. Q: How is Repsol addressing the challenges in the low-carbon generation business, and what is the strategy moving forward? A: Repsol is prioritizing returns over capacity targets, with a focus on capital employed and efficiency. The company aims to have 9 gigawatts of assets in operation by 2027, down from the previous target of 9 to 10 gigawatts, and is exploring opportunities to leverage data centers for increased returns. Q: What is the outlook for Repsol's refining margins and the factors influencing them? A: The refining margin indicator is expected to average $6 per barrel in 2025, supported by higher demand and balanced new refining capacity. The premium over the indicator is projected at $2 per barrel, with improvements driven by energy efficiency programs and better HBO and SAP expectations. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
12-02-2025
- Business
- Yahoo
ams-OSRAM AG (AUKUF) Q4 2024 Earnings Call Highlights: Strategic Wins Amidst Challenging Market ...
Revenue: EUR882 million for Q4, flat quarter over quarter, down 3% year over year. Adjusted EBITDA Margin: Improved by 50 basis points year over year to 17%. Operating Cash Flow: EUR79 million in Q4. CapEx: EUR104 million in Q4, with EUR45 million related to microLED equipment. Free Cash Flow: Positive EUR12 million for the fiscal year 2024. Net Debt: EUR1.85 billion at the end of December 2024. Adjusted Earnings Per Share: Declined from EUR1.61 to EUR0.03 year over year. IFRS Net Result: Improved to negative EUR785 million in 2024. Re-establish the Base Savings: EUR110 million run rate savings implemented by end of 2024. Semiconductor Core Portfolio Growth: 7% year over year. New Business Wins: Close to EUR5 billion for fiscal year 2024. Warning! GuruFocus has detected 4 Warning Signs with AUKUF. Release Date: February 11, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. ams-OSRAM AG (AUKUF) achieved a positive free cash flow of EUR12 million for the fiscal year 2024, marking a significant turnaround from the previous year's negative cash flow. The company reported a 7% revenue growth in its core semiconductor portfolio, driven by new sensor product launches. Re-establish the Base strategic efficiency program exceeded its fiscal year 2024 targets, with EUR110 million in run rate savings implemented. The company secured close to EUR5 billion in new business design wins in 2024, indicating strong customer demand and innovation. ams-OSRAM AG (AUKUF) received the German Future Award for its automotive forward lighting solutions, highlighting its technology leadership. The cancellation of the microLED cornerstone project and weaker auto demand posed significant challenges in 2024. Reported revenues and adjusted EBITDA were down, with the EBITDA margin remaining flat at 16.8%. The company faced a 14% year-over-year decline in its lamps business, attributed to the exit from some OEM module businesses. Adjusted net result declined by EUR47 million year over year, impacted by higher interest costs and normalized income tax costs. The IFRS net result remained negative at EUR785 million for 2024, despite improvements from the previous year. Q: Could you please update on the inventory situation in your main markets, notably the automotive industry? Where are you standing from normal inventory levels? Also, how should we model OpEx for 2025 given the accelerated cost-cutting? A: Inventory levels are relatively normal overall, though slightly high on the industrial side. Automotive inventories are at okay levels. We expect weak demand to continue into Q1 but have seen an uptick in order intake recently. For OpEx, we will generate more savings, and with improving revenues, OpEx as a percentage of revenue will come down in 2025. Non-refundable engineering payments in Q4 were low double digits, and similar amounts are expected going forward. Q: Can you elaborate on the automotive sensor design wins in Q4 and how you see automotive sensors contributing to growth in 2025 and beyond? A: We have several automotive sensors, including position sensing for drive-by-wire systems and hands-on detection for steering wheels. These sensors are becoming more widely used, and we expect them to grow at a solid double-digit rate. Currently, they contribute a lower-digit euro number per quarter but are expected to increase. Q: What gives you confidence in the H2 recovery, given the limited visibility in auto and industrial sectors? A: The design wins and rising content per device are clear trends. We believe the volatility of model push-outs is behind us, and the global car production is expected to remain stable. Recent order upticks suggest inventory levels are low, indicating a potential uptick in demand. Q: Could you provide any color on current utilization rates and how you expect them to trend through the year? A: In Q4, we reduced inventories, leading to lower utilization rates, especially in OS. We expect demand normalization and rising utilization rates throughout the year, with continued investment below 8% of sales. Q: On the free cash flow guidance for 2025, what is your expectation of disposals included in the north of EUR100 million free cash flow? A: The guidance includes minor disposals of some equipment, amounting to a low double-digit number. It does not include any major deals like the [coulomb] deal, which we hope to close in the near future. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
